IRIS
CANTARA, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.723
EU - Europa 6.571
AS - Asia 3.210
SA - Sud America 573
Continente sconosciuto - Info sul continente non disponibili 265
AF - Africa 211
OC - Oceania 17
Totale 18.570
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.550
IT - Italia 1.650
RU - Federazione Russa 1.343
GB - Regno Unito 1.166
SG - Singapore 1.071
CN - Cina 964
IE - Irlanda 734
BR - Brasile 451
SE - Svezia 393
VN - Vietnam 330
DE - Germania 296
FR - Francia 283
HK - Hong Kong 240
UA - Ucraina 231
KR - Corea 174
FI - Finlandia 167
IN - India 124
ZA - Sudafrica 118
CA - Canada 86
NL - Olanda 71
BD - Bangladesh 66
ES - Italia 51
TR - Turchia 48
AR - Argentina 45
PL - Polonia 43
JP - Giappone 37
MX - Messico 30
BE - Belgio 25
IQ - Iraq 24
AT - Austria 22
IR - Iran 22
CI - Costa d'Avorio 21
AU - Australia 15
EC - Ecuador 15
CO - Colombia 14
MA - Marocco 14
CH - Svizzera 13
EG - Egitto 13
VE - Venezuela 13
CL - Cile 12
CZ - Repubblica Ceca 12
JM - Giamaica 11
KE - Kenya 11
LT - Lituania 11
SA - Arabia Saudita 11
GR - Grecia 10
JO - Giordania 10
PK - Pakistan 10
UZ - Uzbekistan 10
ID - Indonesia 9
PH - Filippine 9
DZ - Algeria 8
NG - Nigeria 8
EE - Estonia 7
NP - Nepal 7
PY - Paraguay 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
LV - Lettonia 6
NI - Nicaragua 6
RO - Romania 6
UY - Uruguay 6
HN - Honduras 5
PE - Perù 5
BO - Bolivia 4
GT - Guatemala 4
IL - Israele 4
KZ - Kazakistan 4
AM - Armenia 3
BB - Barbados 3
BG - Bulgaria 3
BS - Bahamas 3
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
KG - Kirghizistan 3
LB - Libano 3
LU - Lussemburgo 3
NO - Norvegia 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
SV - El Salvador 3
TH - Thailandia 3
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GP - Guadalupe 2
IM - Isola di Man 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
Totale 18.288
Salva come PNG Salva come JPEG
Città #
Southend 996
Dallas 833
Dublin 720
Ashburn 665
Fairfield 600
Singapore 578
San Jose 464
Santa Clara 430
Moscow 401
Milan 374
Chandler 347
Woodbridge 236
Seattle 230
Hong Kong 225
Hefei 219
Wilmington 218
Beijing 214
Council Bluffs 205
Houston 196
Jacksonville 183
Cambridge 176
Florence 176
Siena 171
Seoul 169
Ann Arbor 158
Los Angeles 141
Rome 132
New York 126
The Dalles 120
Ho Chi Minh City 107
Johannesburg 107
Munich 97
Princeton 90
Lauterbourg 89
Helsinki 84
Hanoi 68
Nanjing 53
São Paulo 53
Shanghai 46
Buffalo 44
Columbus 44
Boardman 42
Chicago 40
San Diego 39
Poggiomarino 37
Orem 36
Montreal 34
Bengaluru 33
Potenza Picena 33
Warsaw 33
London 32
Turku 32
Redondo Beach 30
San Mateo 30
Atlanta 29
Frankfurt am Main 28
Lappeenranta 28
Brooklyn 27
Tokyo 27
Turin 27
Figino 26
Chennai 25
Phoenix 25
Dearborn 24
Naples 22
Abidjan 21
Lancaster 21
Málaga 21
Brussels 20
Miami 20
Washington 20
Stockholm 19
Tianjin 19
Denver 18
Toronto 18
Amsterdam 17
Izmir 16
Nanchang 16
San Francisco 16
Fremont 15
Manchester 15
Philadelphia 15
Redwood City 15
Belo Horizonte 14
Boston 14
Guangzhou 14
Haiphong 14
Nuremberg 14
Portsmouth 14
Da Nang 13
Düsseldorf 13
Kunming 13
North Bergen 13
Ravenna 13
Rio de Janeiro 13
Shenyang 13
Dong Ket 12
Vienna 12
Zurich 12
Bologna 11
Totale 11.868
Salva come PNG Salva come JPEG
Nome #
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 388
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 374
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 361
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 357
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 356
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 343
Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone 332
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 307
FASTING ENHANCES TKI EFFICACY ON THYROID CANCER CELLS 307
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 305
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 302
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 297
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 296
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 287
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 278
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 275
Clinical significance of type 2 iodothyronine deiodinase polymorphism 267
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 257
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 253
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 253
Role of age at diagnosis in defining potential familial nonmedullary thyroid cancer in kindreds with two affected members 250
Gene-related alterations in four male patients with elevated serum gonadotrophins levels 248
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 245
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 244
Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients 243
Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight 239
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 233
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 233
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 232
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 230
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 228
BROX haploinsufficiency in familial nonmedullary thyroid cancer 222
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 217
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements. 216
Mitigation of UV-B Radiation Stress in Tobacco Pollen by Expression of the Tardigrade Damage Suppressor Protein (Dsup) 216
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 212
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? 212
Follow-up after bariatric surgery: is it time to tailor it? Analysis of early predictive factors of 3-year weight loss predictors of unsuccess in bariatric patients 211
Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma 210
miRNA Targets: From Prediction Tools to Experimental Validation 209
Silent thyroiditis following vaccination against COVID-19: report of two cases 208
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 208
Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients 206
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 206
Proteomics Reveals How the Tardigrade Damage Suppressor Protein Teaches Transfected Human Cells to Survive UV-C Stress 205
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 205
Pilot study on the impact of polymorphisms linked to multi-kinase inhibitor metabolism on lenvatinib side effects in patients with advanced thyroid cancer 204
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 202
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 200
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 200
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 199
Normalization of Spexin Levels in Patients with Obesity Submitted to Bariatric Surgery 196
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred 194
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 193
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer 192
Telomeres and thyroid cancer 191
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 187
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 187
European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics 183
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series 181
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 180
Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade 179
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer 179
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 178
Familial non-medullary thyroid cancer: a critical review 176
Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery 174
HLA class I expression on human platelets is highly variable and correlates with distinct allele group frequencies 166
Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer 165
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium 162
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients 161
Opposite effects of beta amyloid on endothelial cell survival: role of fibroblast growth factor-2 (FGF-2) 159
Eif1ax c.338-2a>t splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion 155
Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything? 155
TAT-BH4 counteracts A beta toxicity on capillary endothelium 149
Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective 142
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value 138
PAPPA expression in indeterminate thyroid nodules as screening test to select patients for molecular testing 137
What's Wrong in a Jump? Prediction and Validation of Splice Site Variants 130
The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology 129
null 126
Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells 122
The impact of CPT1B rs470117, LEPR rs1137101 and BDNF rs6265 polymorphisms on the risk of developing obesity in an Italian population 112
Sex hormone profiles in patients with Torsades de Pointes ventricular tachycardia 100
Telomerase and the endocrine system. 96
Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update 81
Expression of the ring ligase PRAJA2 in thyroid cancer 78
null 60
Investigating the Cytoprotective Mechanisms of the Tardigrade Damage Suppressor (Dsup) Protein in Human Cells Under Hypoxic Stress 53
null 36
Totale 18.570
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022644 0 0 0 86 49 43 36 35 39 88 115 153
2022/20231.302 71 151 151 171 101 259 45 81 141 42 43 46
2023/20241.346 45 43 102 72 90 278 441 66 23 26 48 112
2024/20253.018 87 113 344 271 351 203 89 163 307 162 304 624
2025/20266.911 500 854 640 801 1.188 253 749 254 248 354 339 731
2026/20271.319 309 263 436 311 0 0 0 0 0 0 0 0
Totale 18.570